Medicare Program; Ambulatory Surgical Centers, Conditions for Coverage, 21207-21211 [2010-8903]
Download as PDF
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Proposed Rules
above rules is consistent with EPA’s
definition in 40 CFR 51.100(s). EPA is
proposing to approve this revision.
The March 20, 2009 version
incorporates changes to sections 21.1
and 21.5 that require owners/operators
of VOC stationary storage tanks with
floating roofs to provide additional
emission information concerning roof
landing operations.
EPA evaluated New Jersey’s revisions
for consistency with the Act, EPA
regulations, and EPA policy and
proposes to approve them.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
II. Conclusion
Both Subchapters 16 and 19 contain
provisions which require case-by-case
RACT determinations to be submitted as
SIP revisions. These case-by-case RACT
determinations are needed to fulfill the
RACT requirement of section 182 of the
Act. The State is in the process of
evaluating these determinations for
approval and therefore has not yet
submitted them as SIP revisions. EPA
would normally propose to
conditionally approve this SIP revision
as meeting the RACT requirement
pending New Jersey’s submission and
EPA’s approval of the case-by-case
RACT determinations. However, based
on information provided by New Jersey,
the quantity of NOX and VOC emissions
relevant to these determinations is
below 5 percent of the stationary source
baseline of emissions which is what
EPA considers to be de minimis.
Therefore, pursuant to EPA guidance,5
EPA is proposing to approve
Subchapters 16 and 19. The remaining
element needed to fulfill the VOC RACT
requirement is New Jersey’s Subchapter
26, which New Jersey submitted to EPA
on April 9, 2009, as a SIP revision and
which EPA is currently reviewing.
Therefore, EPA evaluated New
Jersey’s submittal for consistency with
the Act, EPA regulations and policy.
The proposed new control measures
will strengthen the SIP by providing
additional NOX, SO2, fine particulate,
and VOC emission reductions.
Accordingly, EPA is proposing to
approve the revisions to Subchapters 4,
10, 16, 19 and related revisions to
Subchapter 21, as adopted on March 20,
2009, except that EPA is continuing to
not act, for the reasons explained above
in this rulemaking, on the phased
compliance plans by repowering and
innovative control technology in
sections 19.21 and 19.23, respectively.
In addition, EPA is proposing to delete
5 ‘‘Approval Options for Generic RACT Rules
Submitted to Meet the non-CTG VOC RACT
Requirement and Certain NOX RACT
Requirements,’’ November 7, 1996.
VerDate Nov<24>2008
15:48 Apr 22, 2010
Jkt 220001
40 CFR 52.1576, relating to a prior
finding that NOX RACT was not
included in the New Jersey SIP.
III. Statutory and Executive Order
Reviews
Under the Clean Air Act, the
Administrator is required to approve a
SIP submission that complies with the
provisions of the Act and applicable
Federal regulations. 42 U.S.C. 7410(k);
40 CFR 52.02(a). Thus, in reviewing SIP
submissions, EPA’s role is to approve
state choices, provided that they meet
the criteria of the Clean Air Act.
Accordingly, this action merely
approves state law as meeting Federal
requirements and does not impose
additional requirements beyond those
imposed by state law. For that reason,
this action:
• Is not a ‘‘significant regulatory
action’’ subject to review by the Office
of Management and Budget under
Executive Order 12866 (58 FR 51735,
October 4, 1993);
• Does not impose an information
collection burden under the provisions
of the Paperwork Reduction Act (44
U.S.C. 3501 et seq.);
• Is certified as not having a
significant economic impact on a
substantial number of small entities
under the Regulatory Flexibility Act (5
U.S.C. 601 et seq.);
• Does not contain any unfunded
mandate or significantly or uniquely
affect small governments, as described
in the Unfunded Mandates Reform Act
of 1995 (Pub. L. 104–4);
• Does not have Federalism
implications as specified in Executive
Order 13132 (64 FR 43255, August 10,
1999);
• Is not an economically significant
regulatory action based on health or
safety risks subject to Executive Order
13045 (62 FR 19885, April 23, 1997);
• Is not a significant regulatory action
subject to Executive Order 13211 (66 FR
28355, May 22, 2001);
• Is not subject to requirements of
section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (15 U.S.C. 272 note) because
application of those requirements would
be inconsistent with the Clean Air Act;
and
• Does not provide EPA with the
discretionary authority to address, as
appropriate, disproportionate human
health or environmental effects, using
practicable and legally permissible
methods, under Executive Order 12898
(59 FR 7629, February 16, 1994).
In addition, this rule does not have
tribal implications as specified by
Executive Order 13175 (65 FR 67249,
November 9, 2000), because the SIP is
PO 00000
Frm 00017
Fmt 4702
Sfmt 4702
21207
not approved to apply in Indian country
located in the state, and EPA notes that
it will not impose substantial direct
costs on tribal governments or preempt
tribal law.
List of Subjects in 40 CFR Part 52
Environmental protection, Air
pollution control, Intergovernmental
relations, Nitrogen dioxide, Ozone,
Particulate matter, Reporting and
recordkeeping requirements, Sulfur
oxides, Volatile organic compounds.
Authority: 42 U.S.C. 7401 et seq.
Dated: April 14, 2010.
Judith A. Enck,
Regional Administrator, Region 2.
[FR Doc. 2010–9463 Filed 4–22–10; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Service
42 CFR Part 416
[CMS–3217–P]
RIN 0938–AP93
Medicare Program; Ambulatory
Surgical Centers, Conditions for
Coverage
AGENCY: Centers for Medicare &
Medicaid Services (CMS).
ACTION: Proposed rule.
SUMMARY: This proposed rule would
revise one of the existing conditions for
coverage (CfC) that ambulatory surgical
centers (ASCs) must meet in order to
participate in the Medicare program.
The proposed revision would modify
the current CfC for patient rights to
include an exception that would allow
an ASC to provide patients or the
patients’ representative or surrogate
with required patient rights information
on the day of the procedure when the
procedure must, to safeguard the health
of the patient, be performed on the same
day as the physician’s referral. In
addition, we are proposing some other
minor changes to the CfC for patient
right requirements.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. EST on June 22, 2010.
ADDRESSES: In commenting, please refer
to file code CMS–3217–P. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
E:\FR\FM\23APP1.SGM
23APP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
21208
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Proposed Rules
You may submit comments in one of
four ways (please choose only one of the
ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the instructions under the ‘‘More Search
Options’’ tab.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3217–P, P.O. Box 8010, Baltimore,
MD 21244–8010.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–3217–P, Mail
Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
4. By hand or courier. If you prefer,
you may deliver (by hand or courier)
your written comments before the close
of the comment period to either of the
following addresses:
a. For delivery in Washington, DC—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Room 445–G, Hubert
H. Humphrey Building, 200
Independence Avenue, SW.,
Washington, DC 20201.
(Because access to the interior of the
Hubert H. Humphrey Building is not
readily available to persons without
Federal government identification,
commenters are encouraged to leave
their comments in the CMS drop slots
located in the main lobby of the
building. A stamp-in clock is available
for persons wishing to retain a proof of
filing by stamping in and retaining an
extra copy of the comments being filed.)
b. For delivery in Baltimore, MD—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
If you intend to deliver your
comments to the Baltimore address,
please call telephone number (410) 786–
9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses
indicated as appropriate for hand or
courier delivery may be delayed and
received after the comment period.
FOR FURTHER INFORMATION CONTACT: Joan
A. Moliki, (410) 786–5526, Jacqueline
Morgan, (410) 786–4282, Steve Miller,
(410) 786–6656, or Jeannie Miller, (410)
786–3164.
VerDate Nov<24>2008
15:48 Apr 22, 2010
Jkt 220001
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following Web
site as soon as possible after they have
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will also
be available for public inspection as
they are received, generally beginning
approximately 3 weeks after publication
of a document, at the headquarters of
the Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday
through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Background
A. Legislative and Regulatory Authority
for the Ambulatory Surgical Centers,
Conditions for Coverage
As the single largest payer for health
care services in the United States, the
Centers for Medicare & Medicaid
Services (CMS) has a critical role in
promoting high quality care for
Medicare beneficiaries. CMS is
responsible for ensuring that the
conditions for coverage (CfCs) of
Ambulatory Surgical Center (ASC)
services, and enforcement of those
conditions, are adequate to protect the
health and safety of the individuals
treated in such ASCs. Any regulatory
changes that we contemplate must
consider patient health and safety along
with the administrative burden placed
on Medicare-participating facilities.
Section 1832(a)(2)(F)(i) of the Social
Security Act (the Act) specifies that an
ASC must meet health, safety, and other
requirements specified by the Secretary
of Health and Human Services (HHS)
(the Secretary) in regulation if it has an
agreement in effect with the Secretary to
perform procedures covered by
Medicare. Under the agreement, the
ASC agrees to accept the standard
Medicare amount determined under
section 1833(i)(2) of the Act as full
payment for services, and to accept
assignment of benefits as described in
section 1842(b)(3)(B)(ii) of the Act for
payment for all services furnished by
the ASC to enrolled individuals.
Substantive requirements are set forth in
42 CFR part 416 subpart B and subpart
PO 00000
Frm 00018
Fmt 4702
Sfmt 4702
C of our regulations. The regulations at
42 CFR part 416 subpart B describe the
general conditions and requirements for
ASCs, and the regulations at 42 CFR
part 416 subpart C describe the specific
CfCs for ASCs.
B. Updates and Revisions to the
Ambulatory Surgical Centers Conditions
for Coverage
On August 31, 2007, we published a
proposed rule (72 FR 50470) in the
Federal Register entitled, ‘‘Medicare and
Medicaid Programs; Ambulatory
Surgical Centers, Conditions for
Coverage,’’ in which we proposed to
update the ASC CfCs by revising some
of the definitions and the CfCs regarding
governing body and management, and
laboratory and radiologic services, to
reflect current ASC practices. In
addition, we proposed to add several
new CfCs regarding quality assessment
and performance improvement; patient
rights; infection control; and patient
admission, assessment and discharge.
We proposed these CfCs in order to
promote and protect patient health and
safety.
In the proposed rule at § 416.50, we
proposed to divide the patient rights
CfC into four standards. Under the first
standard, § 416.50(a)(1), ‘‘Notice of
rights,’’ we proposed that ASCs be
required to provide the patient or the
patient’s representative with verbal and
written notice of the patient’s rights in
a language and manner the patient
understood in advance of providing care
to the patient. In addition, we set out
what information would be required
and where the ASC would have to post
the information for the patient to see
while waiting for treatment.
On November 18, 2008, we published
a final rule (73 FR 68502), entitled
‘‘Medicare Program; Changes to the
Hospital Outpatient Prospective
Payment System and CY 2009 Payment
Rates’’. The final rule, among other
changes, finalized the new CfC for
patient rights in ASCs. In response to
the proposed patient rights provision,
several commenters expressed concern
about the amount of paperwork patients
would be required to complete on the
day of the procedure and stated that
patients would benefit from reviewing
pertinent information before they
arrived at the ASC for the procedure
(see 73 FR 68718). Therefore, in
response to comments, we revised our
proposed requirement for patient rights
at § 416.50(a)(1), (a)(1)(ii) and (a)(2)(i), to
specify that ambulatory surgical centers
(ASCs) provide patient rights
information to patients or the patient’s
representative in advance of the date of
the procedure.
E:\FR\FM\23APP1.SGM
23APP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Proposed Rules
When we published the final rule for
the ASC CfCs on November 18, 2008, we
specified at § 416.50(a)(1) that patient
rights information was to be provided
by the ASC in advance of the date of the
procedure. It was, and continues to be,
our intent to require that ASCs provide
patients or the patient’s representative
or surrogate with information we
believe they need in order to make an
informed choice about the facility where
their procedure will be performed.
Likewise, we continue to believe that
this information should be imparted in
advance of the date of the procedure.
The patient’s representative or
surrogate, who could be a family
member or friend that accompanies the
patient, may act as a liaison between the
patient and the ASC to help the patient
communicate, understand, remember,
and cope with the interactions that take
place during the visit, and explain any
instructions to the patient that are
delivered by the ASC staff. If a patient
is unable to fully communicate directly
with the ASC staff, then the ASC may
give patient rights information to the
patient’s representative or surrogate.
The patient has the choice of using an
interpreter of his or her own, or one
supplied by the ASC. A professional
interpreter is not considered to be a
patient’s representative or surrogate.
Rather, it is the professional
interpreter’s role to pass information
from the ASC to the patient. In
following translation practices, we
recommend, but do not propose
requiring, that a written translation be
provided in languages that non-English
speaking clients can read, particularly
for languages that are most commonly
used by non-English-speaking clients of
the ASC. We note that there are many
hundreds of languages (not all written)
that are used by one or more residents
of the United State, but that in most
geographic areas the most common nonEnglish language, by far, is Spanish.
While we propose this standard under
the authority of title 18, section
1832(a)(2)(F)(i), there are other legal
requirements, most notably, those under
title VI of the Civil Rights Act of 1964.
Our proposed requirement has been
designed to be compatible with recent
guidance on title VI. The Department of
Health and Human Services’ (HHS)
guidance related to Title VI of the Civil
Rights Act of 1964, ‘‘Guidance to Federal
Financial Assistance Recipients
Regarding Title VI Prohibition Against
National Origin Discrimination
Affecting Limited English Proficient
Persons’’ (August 8, 2003, 68 FR 47311)
applies to those entities that receive
federal financial assistance from HHS,
including ASCs. This guidance may
VerDate Nov<24>2008
15:48 Apr 22, 2010
Jkt 220001
assist ASCs in ensuring that patient
rights information is provided in a
language and manner the Medicare
patient understands.
In the November 18, 2008, ASC
regulation, we also specified at
§ 416.50(a)(1)(ii) (physician financial
interest or ownership), and
§ 416.50(a)(2)(i) (Advance directives)
that ASCs are also required to provide
this information to patients in advance
of the date of the procedure. We believe
that the current organization of § 416.50
is confusing relative to the need for
ASCs to furnish information to patients
prior to the date of the procedure.
Therefore, we are proposing to revise
this section.
II. Provisions of the Proposed
Regulation
As stated above, the November 18,
2008 final rule finalized the patient’s
right provision at § 416.50, to require
ASCs to provide specific patients’ rights
information to patients in advance of
the date of the procedure. We believed
this modification would alleviate
provider concerns while at the same
time afford patients sufficient time to
review pertinent information before
undergoing a procedure. However, since
the publication of the final rule, it has
come to our attention that a few ASCs
sometimes provide same-day
procedures on an emergency basis.
Therefore, the current patient rights CfC
requirement has been problematic for
those ASCs that perform procedures on
the same day they receive physician
referrals (for example, a patient is
referred to an ASC due to severe eye
trauma).
ASCs contemplating providing
services to a patient on the same day he
or she receives a referral must either
refuse serving the patient for fear of
violating Medicare requirements or
accept the patient for service and be out
of compliance with Medicare patient
rights requirements. ASCs that serve
same-day patients would like to
continue to serve this constituency;
however, potential non-compliance
with the current Medicare requirement
is a deterrent.
This rule proposes to establish an
exception when an ASC is providing
services to a patient on the same day he
or she receives a physician referral for
the ASC service(s) and when a delay in
providing the service(s) would
adversely affect the patient’s health. In
general, the ASC would continue to be
required to provide information as
specified at § 416.50. However, the
proposed exception would apply only
if: (1) The written referral was signed
and dated by the physician on the date
PO 00000
Frm 00019
Fmt 4702
Sfmt 4702
21209
the patient was presented at the ASC for
the service(s); and (2) a physician in the
ASC or the referring physician
communicates in writing and the ASC
documents in the medical record that
the procedure must be performed as
soon as possible to safeguard the health
of the patient. This proposed exception
attempts to balance our responsibility to
promote the health and safety of ASC
patients with undue burden on
facilities.
In addition to modifying § 416.50 to
provide for an exception for same-day
procedures, we are proposing minor
revisions to this section. Currently
§ 416.50(a)(1) and (a)(2) require
disclosure of information to be made in
advance of the date of the procedure.
We are proposing to eliminate this
specific requirement from these sections
and add this requirement to the stem
statement at § 416.50 since the stem
statement applies to all of the proposed
requirements at § 416.50.
The current provisions at § 416.50(a),
(b), and (c) require that an ASC provide
verbal and written notice of patient
rights to the patient or the patient’s
representative. This encompasses the
posting of rights, disclosure of physician
financial interest or ownership, the
provision of advance directives, the
submission and investigation of
grievances, the exercise of rights,
privacy and safety, and the
confidentiality of clinical records. We
are proposing to reorganize § 416.50(a),
(b), and (c) by creating separate
standards for provisions that are
currently required in these paragraphs.
Specifically, we are proposing to retitle
and reorganize the requirements of
§ 416.50, ‘‘Patient rights,’’ as follows: (a)
Standard: Notice of rights; (b) Standard:
Disclosure of physician financial
interest or ownership; (c) Standard:
Advance directives; (d) Standard:
Submission and investigation of
grievances; (e) Standard: Exercise of
rights and respect for property and
person; (f) Standard: Privacy and safety;
(g) Standard: Confidentiality of medical
records; and (h) Standard: Exception to
the timing of the notice of patient rights.
We believe this reorganization would
eliminate confusion about the patient
rights information to be provided to
patients. We note that these are not new
requirements.
In addition, as stated above, we are
proposing to add a new exception to
§ 416.50 (proposed Standard (h)) that
would allow an ASC in the case of an
emergency procedure, and when it was
not feasible to provide notice of patient
rights information in advance of the
date of the procedure, to provide this
information to the patient or the
E:\FR\FM\23APP1.SGM
23APP1
21210
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Proposed Rules
patient’s representative or surrogate on
the day of treatment before the
procedure.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
III. Collection of Information
Requirements
Under the Paperwork Reduction Act
of 1995, we are required to provide 60day notice in the Federal Register and
solicit public comment before a
collection of information requirement is
submitted to the Office of Management
and Budget (OMB) for review and
approval. In order to fairly evaluate
whether an information collection
should be approved by OMB, section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires that we
solicit comments on the following
issues:
• The need for the information
collection and its usefulness in carrying
out the proper functions of our agency.
• The accuracy of our estimate of the
information collection burden.
• The quality, utility, and clarity of
the information to be collected.
• Recommendations to minimize the
information collection burden on the
affected public, including automated
collection techniques.
Proposed § 416.50 (h)(1) and (h)(2)
would require an ASC facility to furnish
information as specified when an ASC
accepts a patient for a procedure that
must be performed on the same day as
a physician referral. Specifically,
proposed § 416.50(h)(2) states that a
physician in the ASC or the referring
physician must communicate in writing
and the ASC must document in the
medical record that the procedure be
performed as soon as possible to
safeguard the health of the patient. The
burden associated with this requirement
is the time and effort necessary for an
ASC physician or a referring physician
to make the aforementioned written
communication and documentation.
We believe the burden associated
with this requirement in proposed
§ 416.50 constitutes a usual and
customary business practice as defined
in 5 CFR 1320.3(b)(2). The medical
record requirement at § 416.47, which
remains unchanged, also specifies that
ASCs must maintain complete,
comprehensive and accurate medical
records to ensure adequate patient care.
A physician referral letter is considered
part of the patient’s medical history and
is always part of the medical record.
If you comment on these information
collection and recordkeeping
requirements, please do either of the
following:
1. Submit your comments
electronically as specified in the
VerDate Nov<24>2008
15:48 Apr 22, 2010
Jkt 220001
ADDRESSES
section of this proposed rule;
or
2. Submit your comments to the
Office of Information and Regulatory
Affairs, Office of Management and
Budget, Attention: CMS Desk Officer,
CMS–3217–P, Fax: (202) 395–6974; or
E-mail: OIRA_submission@omb.eop.gov.
IV. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
V. Regulatory Impact Statement
We have examined the impacts of this
rule as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993), the
Regulatory Flexibility Act (RFA)
(September 19, 1980, Pub. L. 96–354),
section 1102(b) of the Social Security
Act, section 202 of the Unfunded
Mandates Reform Act of 1995 (Pub. L.
104–4), Executive Order 13132 on
Federalism (August 4, 1999), and the
Congressional Review Act (5 U.S.C.
804(2)).
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
if regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, distributive impacts,
and equity). A regulatory impact
analysis (RIA) must be prepared for
major rules with economically
significant effects ($100 million or more
in any 1 year). This rule does not reach
the economic threshold and thus is not
considered a major rule.
The RFA requires agencies to analyze
options for regulatory relief of small
businesses. For purposes of the RFA,
small entities include small businesses,
nonprofit organizations, and small
governmental jurisdictions. Most
hospitals and most other providers and
suppliers are small entities, either by
nonprofit status or by having revenues
of $7.0 million to $34.5 million in any
1 year. Individuals and States are not
included in the definition of a small
entity. We estimate there are
approximately 5,100 Medicare
Participating ASCs with average
admissions of approximately 1,240
patients per ASC (based on the number
of patients seen in ASCs in 2008). Most
PO 00000
Frm 00020
Fmt 4702
Sfmt 4702
ASCs are considered to be small
entities, either by nonprofit status or by
having revenues of $7 million to $34.5
million in any 1 year. For purposes of
burden estimates, we are unable to
accurately determine the exact number
of ASCs that provide services to patients
on the same day as referral by their
physicians. However, one national ASC
chain informed us in September 2009
that approximately 3 percent of its ASCs
provide services to patients on the same
day as referral by their physicians.
Using this percentage, we estimate that
153 ASCs overall perform these same
day services. Due to this small
percentage, we have determined that the
ASC industry on average will
experience a slightly reduced burden
associated with mailing out patient
rights informational packets to patients
prior to providing the service(s).
Instead, a small percentage of patients
would be informed in person on the day
of the procedure. Thus, we believe this
exception rule should have little or no
effect on the benefit cost of ASC
services.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 603 of the
RFA. However, this proposed rule only
affects ambulatory surgical centers and
not hospitals. As a result, we are not
preparing an analysis for section 1102(b)
of the Act because we believe and the
Secretary has determined that this rule
will not have a significant impact on the
operations of a substantial number of
small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule whose mandates require spending
in any 1 year by State, local or tribal
governments, in the aggregate, or by the
private sector of $100 million in 1995
dollars, updated annually for inflation.
In 2010, that threshold level is
approximately $135 million. This
proposed rule is not expected to reach
this spending threshold.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on State and local
governments, preempts State law, or
otherwise has Federalism implications.
This proposed rule has no Federalism
implications and does not impose any
costs on State or local governments.
Therefore, the requirements of
E:\FR\FM\23APP1.SGM
23APP1
Federal Register / Vol. 75, No. 78 / Friday, April 23, 2010 / Proposed Rules
Executive Order 13132 are not
applicable.
In accordance with the provisions of
Executive Order 12866, this regulation
was not reviewed by the Office of
Management and Budget.
List of Subjects in 42 CFR Part 416
Health facilities, Health professions,
Medicare, Reporting and recordkeeping
requirements.
For the reasons set forth in the
preamble, the Centers for Medicare &
Medicaid Services proposes to amend
42 CFR part 416 as set forth below:
PART 416—AMBULATORY SURGICAL
SERVICES
1. The authority citation for part 416
continues to read as follows:
Authority: Secs. 1102 and 1871 of the
Social Security Act (42 U.S.C. 1302 and
1395hh).
Subpart C—Specific Conditions for
Coverage
2. Section 416.50 is revised to read as
follows:
mstockstill on DSKH9S0YB1PROD with PROPOSALS
§ 416.50
rights.
Condition for coverage—Patient
The ASC must inform the patient or
the patient’s representative or surrogate
of the patient’s rights and must protect
and promote the exercise of these rights,
as set forth in this section. The ASC
must also post the written notice of
patient rights in a place or places within
the ASC likely to be noticed by patients
waiting for treatment or by the patient’s
representative or surrogate, if
applicable.
(a) Standard: Notice of rights. Except
as set forth in paragraph (h) of this
section, an ASC must, in advance of the
date of the procedure, provide the
patient or the patient’s representative or
surrogate with verbal and written notice
of the patient’s rights in a language and
manner that ensures the patient or the
patient’s representative or surrogate
understands all of the patient’s rights as
set forth in this section. The ASC’s
notice of rights must include the
address and telephone number of the
State agency to whom patients may
report complaints as well as the Web
site for the Office of the Medicare
Beneficiary Ombudsman.
(b) Standard: Disclosure of physician
financial interest or ownership. The
ASC must disclose, in accordance with
Part 420 of this subchapter, and where
applicable, provide a list of physicians
who have financial interest or
ownership in the ASC facility.
Disclosure of information must be in
writing.
VerDate Nov<24>2008
15:48 Apr 22, 2010
Jkt 220001
(c) Standard: Advance directives. The
ASC must comply with the following
requirements:
(1) Provide the patient or, as
appropriate, the patient’s representative
or surrogate with written information
concerning its policies on advance
directives, including a description of
applicable State health and safety laws
and, if requested, official State advance
directive forms.
(2) Inform the patient or, as
appropriate, the patient’s representative
or surrogate of the patient’s right to
make informed decisions regarding the
patient’s care.
(3) Document in a prominent part of
the patient’s current medical record,
whether or not the individual has
executed an advance directive.
(d) Standard: Submission and
investigation of grievances. The ASC
must establish a grievance procedure for
documenting the existence, submission,
investigation, and disposition of a
patient’s written or verbal grievance to
the ASC. The following criteria must be
met:
(1) All alleged violations/grievances
relating, but not limited to,
mistreatment, neglect, verbal, mental,
sexual, or physical abuse, must be fully
documented.
(2) Allegations of neglect,
mistreatment, sexual or physical abuse
must be immediately reported to a
person in authority in the ASC.
(3) Only substantiated allegations of
neglect, mistreatment, sexual or
physical abuse must be reported to the
applicable State authority or the local
authority, or both.
(4) The grievance process must
specify timeframes for review of the
grievance and the provisions of a
response.
(5) The ASC, in responding to the
grievance, must investigate all
grievances made by a patient or the
patient’s representative or surrogate
regarding treatment or care that is (or
fails to be) furnished.
(6) The ASC must document how the
grievance was addressed, as well as
provide the patient with written notice
of its decision. The decision must
contain the name of an ASC contact
person, the steps taken to investigate the
grievance, the result of the grievance
process, and the date the grievance
process was completed.
(e) Standard: Exercise of rights and
respect for property and person.
(1) The patient has the right to
(i) Be free from any act of
discrimination or reprisal.
(ii) Voice grievances regarding
treatment or care that is (or fails to be)
provided.
PO 00000
Frm 00021
Fmt 4702
Sfmt 9990
21211
(iii) Be fully informed about a
treatment or procedure and the expected
outcome before it is performed.
(2) If a patient is adjudged
incompetent under applicable State
health and safety laws by a court of
proper jurisdiction, the rights of the
patient are exercised by the person
appointed under State law to act on the
patient’s behalf.
(3) If a State court has not adjudged
a patient incompetent, any legal
representative or surrogate designated
by the patient in accordance with State
law may exercise the patient’s rights to
the extent allowed by State law.
(f) Standard: Privacy and safety. The
patient has the right to the following:
(1) Personal privacy.
(2) Receive care in a safe setting.
(3) Be free from all forms of abuse or
harassment.
(g) Standard: Confidentiality of
medical records. The ASC must comply
with the Department’s rules for the
privacy and security of individually
identifiable health information, as
specified at 45 CFR parts 160 and 164.
(h) Standard: Exception to the timing
of the notice of patient rights. In the
case of an emergency procedure, when
it is not feasible to inform the patient or
the patient’s representative or surrogate
of the patient’s rights in advance of the
date of the procedure, the ASC may
provide the required notice and
disclosures to the patient or the
patient’s representative or surrogate
immediately before the procedure only
if the following conditions are met:
(1) The signed physician referral is in
writing, is dated the day the patient
presents at the ASC, and is placed in the
patient’s medical record prior to the
procedure.
(2) A physician in the ASC or the
referring physician communicates in
writing and the ASC documents in the
medical record that the procedure must
be performed as soon as possible to
safeguard the health of the patient.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: January 21, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
Approved: April 5, 2010.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010–8903 Filed 4–22–10; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\23APP1.SGM
23APP1
Agencies
[Federal Register Volume 75, Number 78 (Friday, April 23, 2010)]
[Proposed Rules]
[Pages 21207-21211]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8903]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Service
42 CFR Part 416
[CMS-3217-P]
RIN 0938-AP93
Medicare Program; Ambulatory Surgical Centers, Conditions for
Coverage
AGENCY: Centers for Medicare & Medicaid Services (CMS).
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: This proposed rule would revise one of the existing conditions
for coverage (CfC) that ambulatory surgical centers (ASCs) must meet in
order to participate in the Medicare program. The proposed revision
would modify the current CfC for patient rights to include an exception
that would allow an ASC to provide patients or the patients'
representative or surrogate with required patient rights information on
the day of the procedure when the procedure must, to safeguard the
health of the patient, be performed on the same day as the physician's
referral. In addition, we are proposing some other minor changes to the
CfC for patient right requirements.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. EST on June 22,
2010.
ADDRESSES: In commenting, please refer to file code CMS-3217-P. Because
of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
[[Page 21208]]
You may submit comments in one of four ways (please choose only one
of the ways listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the instructions under
the ``More Search Options'' tab.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-3217-P, P.O. Box 8010,
Baltimore, MD 21244-8010.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-3217-P, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
4. By hand or courier. If you prefer, you may deliver (by hand or
courier) your written comments before the close of the comment period
to either of the following addresses:
a. For delivery in Washington, DC--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, Room 445-G, Hubert
H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC
20201.
(Because access to the interior of the Hubert H. Humphrey Building
is not readily available to persons without Federal government
identification, commenters are encouraged to leave their comments in
the CMS drop slots located in the main lobby of the building. A stamp-
in clock is available for persons wishing to retain a proof of filing
by stamping in and retaining an extra copy of the comments being
filed.)
b. For delivery in Baltimore, MD--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, 7500 Security
Boulevard, Baltimore, MD 21244-1850.
If you intend to deliver your comments to the Baltimore address,
please call telephone number (410) 786-9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses indicated as appropriate for hand
or courier delivery may be delayed and received after the comment
period.
FOR FURTHER INFORMATION CONTACT: Joan A. Moliki, (410) 786-5526,
Jacqueline Morgan, (410) 786-4282, Steve Miller, (410) 786-6656, or
Jeannie Miller, (410) 786-3164.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following Web
site as soon as possible after they have been received: https://www.regulations.gov. Follow the search instructions on that Web site to
view public comments.
Comments received timely will also be available for public
inspection as they are received, generally beginning approximately 3
weeks after publication of a document, at the headquarters of the
Centers for Medicare & Medicaid Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an appointment to view public comments,
phone 1-800-743-3951.
I. Background
A. Legislative and Regulatory Authority for the Ambulatory Surgical
Centers, Conditions for Coverage
As the single largest payer for health care services in the United
States, the Centers for Medicare & Medicaid Services (CMS) has a
critical role in promoting high quality care for Medicare
beneficiaries. CMS is responsible for ensuring that the conditions for
coverage (CfCs) of Ambulatory Surgical Center (ASC) services, and
enforcement of those conditions, are adequate to protect the health and
safety of the individuals treated in such ASCs. Any regulatory changes
that we contemplate must consider patient health and safety along with
the administrative burden placed on Medicare-participating facilities.
Section 1832(a)(2)(F)(i) of the Social Security Act (the Act)
specifies that an ASC must meet health, safety, and other requirements
specified by the Secretary of Health and Human Services (HHS) (the
Secretary) in regulation if it has an agreement in effect with the
Secretary to perform procedures covered by Medicare. Under the
agreement, the ASC agrees to accept the standard Medicare amount
determined under section 1833(i)(2) of the Act as full payment for
services, and to accept assignment of benefits as described in section
1842(b)(3)(B)(ii) of the Act for payment for all services furnished by
the ASC to enrolled individuals. Substantive requirements are set forth
in 42 CFR part 416 subpart B and subpart C of our regulations. The
regulations at 42 CFR part 416 subpart B describe the general
conditions and requirements for ASCs, and the regulations at 42 CFR
part 416 subpart C describe the specific CfCs for ASCs.
B. Updates and Revisions to the Ambulatory Surgical Centers Conditions
for Coverage
On August 31, 2007, we published a proposed rule (72 FR 50470) in
the Federal Register entitled, ``Medicare and Medicaid Programs;
Ambulatory Surgical Centers, Conditions for Coverage,'' in which we
proposed to update the ASC CfCs by revising some of the definitions and
the CfCs regarding governing body and management, and laboratory and
radiologic services, to reflect current ASC practices. In addition, we
proposed to add several new CfCs regarding quality assessment and
performance improvement; patient rights; infection control; and patient
admission, assessment and discharge. We proposed these CfCs in order to
promote and protect patient health and safety.
In the proposed rule at Sec. 416.50, we proposed to divide the
patient rights CfC into four standards. Under the first standard, Sec.
416.50(a)(1), ``Notice of rights,'' we proposed that ASCs be required
to provide the patient or the patient's representative with verbal and
written notice of the patient's rights in a language and manner the
patient understood in advance of providing care to the patient. In
addition, we set out what information would be required and where the
ASC would have to post the information for the patient to see while
waiting for treatment.
On November 18, 2008, we published a final rule (73 FR 68502),
entitled ``Medicare Program; Changes to the Hospital Outpatient
Prospective Payment System and CY 2009 Payment Rates''. The final rule,
among other changes, finalized the new CfC for patient rights in ASCs.
In response to the proposed patient rights provision, several
commenters expressed concern about the amount of paperwork patients
would be required to complete on the day of the procedure and stated
that patients would benefit from reviewing pertinent information before
they arrived at the ASC for the procedure (see 73 FR 68718). Therefore,
in response to comments, we revised our proposed requirement for
patient rights at Sec. 416.50(a)(1), (a)(1)(ii) and (a)(2)(i), to
specify that ambulatory surgical centers (ASCs) provide patient rights
information to patients or the patient's representative in advance of
the date of the procedure.
[[Page 21209]]
When we published the final rule for the ASC CfCs on November 18,
2008, we specified at Sec. 416.50(a)(1) that patient rights
information was to be provided by the ASC in advance of the date of the
procedure. It was, and continues to be, our intent to require that ASCs
provide patients or the patient's representative or surrogate with
information we believe they need in order to make an informed choice
about the facility where their procedure will be performed. Likewise,
we continue to believe that this information should be imparted in
advance of the date of the procedure.
The patient's representative or surrogate, who could be a family
member or friend that accompanies the patient, may act as a liaison
between the patient and the ASC to help the patient communicate,
understand, remember, and cope with the interactions that take place
during the visit, and explain any instructions to the patient that are
delivered by the ASC staff. If a patient is unable to fully communicate
directly with the ASC staff, then the ASC may give patient rights
information to the patient's representative or surrogate. The patient
has the choice of using an interpreter of his or her own, or one
supplied by the ASC. A professional interpreter is not considered to be
a patient's representative or surrogate. Rather, it is the professional
interpreter's role to pass information from the ASC to the patient. In
following translation practices, we recommend, but do not propose
requiring, that a written translation be provided in languages that
non-English speaking clients can read, particularly for languages that
are most commonly used by non-English-speaking clients of the ASC. We
note that there are many hundreds of languages (not all written) that
are used by one or more residents of the United State, but that in most
geographic areas the most common non-English language, by far, is
Spanish.
While we propose this standard under the authority of title 18,
section 1832(a)(2)(F)(i), there are other legal requirements, most
notably, those under title VI of the Civil Rights Act of 1964. Our
proposed requirement has been designed to be compatible with recent
guidance on title VI. The Department of Health and Human Services'
(HHS) guidance related to Title VI of the Civil Rights Act of 1964,
``Guidance to Federal Financial Assistance Recipients Regarding Title
VI Prohibition Against National Origin Discrimination Affecting Limited
English Proficient Persons'' (August 8, 2003, 68 FR 47311) applies to
those entities that receive federal financial assistance from HHS,
including ASCs. This guidance may assist ASCs in ensuring that patient
rights information is provided in a language and manner the Medicare
patient understands.
In the November 18, 2008, ASC regulation, we also specified at
Sec. 416.50(a)(1)(ii) (physician financial interest or ownership), and
Sec. 416.50(a)(2)(i) (Advance directives) that ASCs are also required
to provide this information to patients in advance of the date of the
procedure. We believe that the current organization of Sec. 416.50 is
confusing relative to the need for ASCs to furnish information to
patients prior to the date of the procedure. Therefore, we are
proposing to revise this section.
II. Provisions of the Proposed Regulation
As stated above, the November 18, 2008 final rule finalized the
patient's right provision at Sec. 416.50, to require ASCs to provide
specific patients' rights information to patients in advance of the
date of the procedure. We believed this modification would alleviate
provider concerns while at the same time afford patients sufficient
time to review pertinent information before undergoing a procedure.
However, since the publication of the final rule, it has come to our
attention that a few ASCs sometimes provide same-day procedures on an
emergency basis. Therefore, the current patient rights CfC requirement
has been problematic for those ASCs that perform procedures on the same
day they receive physician referrals (for example, a patient is
referred to an ASC due to severe eye trauma).
ASCs contemplating providing services to a patient on the same day
he or she receives a referral must either refuse serving the patient
for fear of violating Medicare requirements or accept the patient for
service and be out of compliance with Medicare patient rights
requirements. ASCs that serve same-day patients would like to continue
to serve this constituency; however, potential non-compliance with the
current Medicare requirement is a deterrent.
This rule proposes to establish an exception when an ASC is
providing services to a patient on the same day he or she receives a
physician referral for the ASC service(s) and when a delay in providing
the service(s) would adversely affect the patient's health. In general,
the ASC would continue to be required to provide information as
specified at Sec. 416.50. However, the proposed exception would apply
only if: (1) The written referral was signed and dated by the physician
on the date the patient was presented at the ASC for the service(s);
and (2) a physician in the ASC or the referring physician communicates
in writing and the ASC documents in the medical record that the
procedure must be performed as soon as possible to safeguard the health
of the patient. This proposed exception attempts to balance our
responsibility to promote the health and safety of ASC patients with
undue burden on facilities.
In addition to modifying Sec. 416.50 to provide for an exception
for same-day procedures, we are proposing minor revisions to this
section. Currently Sec. 416.50(a)(1) and (a)(2) require disclosure of
information to be made in advance of the date of the procedure. We are
proposing to eliminate this specific requirement from these sections
and add this requirement to the stem statement at Sec. 416.50 since
the stem statement applies to all of the proposed requirements at Sec.
416.50.
The current provisions at Sec. 416.50(a), (b), and (c) require
that an ASC provide verbal and written notice of patient rights to the
patient or the patient's representative. This encompasses the posting
of rights, disclosure of physician financial interest or ownership, the
provision of advance directives, the submission and investigation of
grievances, the exercise of rights, privacy and safety, and the
confidentiality of clinical records. We are proposing to reorganize
Sec. 416.50(a), (b), and (c) by creating separate standards for
provisions that are currently required in these paragraphs.
Specifically, we are proposing to retitle and reorganize the
requirements of Sec. 416.50, ``Patient rights,'' as follows: (a)
Standard: Notice of rights; (b) Standard: Disclosure of physician
financial interest or ownership; (c) Standard: Advance directives; (d)
Standard: Submission and investigation of grievances; (e) Standard:
Exercise of rights and respect for property and person; (f) Standard:
Privacy and safety; (g) Standard: Confidentiality of medical records;
and (h) Standard: Exception to the timing of the notice of patient
rights. We believe this reorganization would eliminate confusion about
the patient rights information to be provided to patients. We note that
these are not new requirements.
In addition, as stated above, we are proposing to add a new
exception to Sec. 416.50 (proposed Standard (h)) that would allow an
ASC in the case of an emergency procedure, and when it was not feasible
to provide notice of patient rights information in advance of the date
of the procedure, to provide this information to the patient or the
[[Page 21210]]
patient's representative or surrogate on the day of treatment before
the procedure.
III. Collection of Information Requirements
Under the Paperwork Reduction Act of 1995, we are required to
provide 60-day notice in the Federal Register and solicit public
comment before a collection of information requirement is submitted to
the Office of Management and Budget (OMB) for review and approval. In
order to fairly evaluate whether an information collection should be
approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act
of 1995 requires that we solicit comments on the following issues:
The need for the information collection and its usefulness
in carrying out the proper functions of our agency.
The accuracy of our estimate of the information collection
burden.
The quality, utility, and clarity of the information to be
collected.
Recommendations to minimize the information collection
burden on the affected public, including automated collection
techniques.
Proposed Sec. 416.50 (h)(1) and (h)(2) would require an ASC
facility to furnish information as specified when an ASC accepts a
patient for a procedure that must be performed on the same day as a
physician referral. Specifically, proposed Sec. 416.50(h)(2) states
that a physician in the ASC or the referring physician must communicate
in writing and the ASC must document in the medical record that the
procedure be performed as soon as possible to safeguard the health of
the patient. The burden associated with this requirement is the time
and effort necessary for an ASC physician or a referring physician to
make the aforementioned written communication and documentation.
We believe the burden associated with this requirement in proposed
Sec. 416.50 constitutes a usual and customary business practice as
defined in 5 CFR 1320.3(b)(2). The medical record requirement at Sec.
416.47, which remains unchanged, also specifies that ASCs must maintain
complete, comprehensive and accurate medical records to ensure adequate
patient care. A physician referral letter is considered part of the
patient's medical history and is always part of the medical record.
If you comment on these information collection and recordkeeping
requirements, please do either of the following:
1. Submit your comments electronically as specified in the
ADDRESSES section of this proposed rule; or
2. Submit your comments to the Office of Information and Regulatory
Affairs, Office of Management and Budget, Attention: CMS Desk Officer,
CMS-3217-P, Fax: (202) 395-6974; or E-mail: OIRA_submission@omb.eop.gov.
IV. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
V. Regulatory Impact Statement
We have examined the impacts of this rule as required by Executive
Order 12866 on Regulatory Planning and Review (September 30, 1993), the
Regulatory Flexibility Act (RFA) (September 19, 1980, Pub. L. 96-354),
section 1102(b) of the Social Security Act, section 202 of the Unfunded
Mandates Reform Act of 1995 (Pub. L. 104-4), Executive Order 13132 on
Federalism (August 4, 1999), and the Congressional Review Act (5 U.S.C.
804(2)).
Executive Order 12866 directs agencies to assess all costs and
benefits of available regulatory alternatives and, if regulation is
necessary, to select regulatory approaches that maximize net benefits
(including potential economic, environmental, public health and safety
effects, distributive impacts, and equity). A regulatory impact
analysis (RIA) must be prepared for major rules with economically
significant effects ($100 million or more in any 1 year). This rule
does not reach the economic threshold and thus is not considered a
major rule.
The RFA requires agencies to analyze options for regulatory relief
of small businesses. For purposes of the RFA, small entities include
small businesses, nonprofit organizations, and small governmental
jurisdictions. Most hospitals and most other providers and suppliers
are small entities, either by nonprofit status or by having revenues of
$7.0 million to $34.5 million in any 1 year. Individuals and States are
not included in the definition of a small entity. We estimate there are
approximately 5,100 Medicare Participating ASCs with average admissions
of approximately 1,240 patients per ASC (based on the number of
patients seen in ASCs in 2008). Most ASCs are considered to be small
entities, either by nonprofit status or by having revenues of $7
million to $34.5 million in any 1 year. For purposes of burden
estimates, we are unable to accurately determine the exact number of
ASCs that provide services to patients on the same day as referral by
their physicians. However, one national ASC chain informed us in
September 2009 that approximately 3 percent of its ASCs provide
services to patients on the same day as referral by their physicians.
Using this percentage, we estimate that 153 ASCs overall perform these
same day services. Due to this small percentage, we have determined
that the ASC industry on average will experience a slightly reduced
burden associated with mailing out patient rights informational packets
to patients prior to providing the service(s). Instead, a small
percentage of patients would be informed in person on the day of the
procedure. Thus, we believe this exception rule should have little or
no effect on the benefit cost of ASC services.
In addition, section 1102(b) of the Act requires us to prepare a
regulatory impact analysis if a rule may have a significant impact on
the operations of a substantial number of small rural hospitals. This
analysis must conform to the provisions of section 603 of the RFA.
However, this proposed rule only affects ambulatory surgical centers
and not hospitals. As a result, we are not preparing an analysis for
section 1102(b) of the Act because we believe and the Secretary has
determined that this rule will not have a significant impact on the
operations of a substantial number of small rural hospitals.
Section 202 of the Unfunded Mandates Reform Act of 1995 also
requires that agencies assess anticipated costs and benefits before
issuing any rule whose mandates require spending in any 1 year by
State, local or tribal governments, in the aggregate, or by the private
sector of $100 million in 1995 dollars, updated annually for inflation.
In 2010, that threshold level is approximately $135 million. This
proposed rule is not expected to reach this spending threshold.
Executive Order 13132 establishes certain requirements that an
agency must meet when it promulgates a proposed rule (and subsequent
final rule) that imposes substantial direct requirement costs on State
and local governments, preempts State law, or otherwise has Federalism
implications. This proposed rule has no Federalism implications and
does not impose any costs on State or local governments. Therefore, the
requirements of
[[Page 21211]]
Executive Order 13132 are not applicable.
In accordance with the provisions of Executive Order 12866, this
regulation was not reviewed by the Office of Management and Budget.
List of Subjects in 42 CFR Part 416
Health facilities, Health professions, Medicare, Reporting and
recordkeeping requirements.
For the reasons set forth in the preamble, the Centers for Medicare
& Medicaid Services proposes to amend 42 CFR part 416 as set forth
below:
PART 416--AMBULATORY SURGICAL SERVICES
1. The authority citation for part 416 continues to read as
follows:
Authority: Secs. 1102 and 1871 of the Social Security Act (42
U.S.C. 1302 and 1395hh).
Subpart C--Specific Conditions for Coverage
2. Section 416.50 is revised to read as follows:
Sec. 416.50 Condition for coverage--Patient rights.
The ASC must inform the patient or the patient's representative or
surrogate of the patient's rights and must protect and promote the
exercise of these rights, as set forth in this section. The ASC must
also post the written notice of patient rights in a place or places
within the ASC likely to be noticed by patients waiting for treatment
or by the patient's representative or surrogate, if applicable.
(a) Standard: Notice of rights. Except as set forth in paragraph
(h) of this section, an ASC must, in advance of the date of the
procedure, provide the patient or the patient's representative or
surrogate with verbal and written notice of the patient's rights in a
language and manner that ensures the patient or the patient's
representative or surrogate understands all of the patient's rights as
set forth in this section. The ASC's notice of rights must include the
address and telephone number of the State agency to whom patients may
report complaints as well as the Web site for the Office of the
Medicare Beneficiary Ombudsman.
(b) Standard: Disclosure of physician financial interest or
ownership. The ASC must disclose, in accordance with Part 420 of this
subchapter, and where applicable, provide a list of physicians who have
financial interest or ownership in the ASC facility. Disclosure of
information must be in writing.
(c) Standard: Advance directives. The ASC must comply with the
following requirements:
(1) Provide the patient or, as appropriate, the patient's
representative or surrogate with written information concerning its
policies on advance directives, including a description of applicable
State health and safety laws and, if requested, official State advance
directive forms.
(2) Inform the patient or, as appropriate, the patient's
representative or surrogate of the patient's right to make informed
decisions regarding the patient's care.
(3) Document in a prominent part of the patient's current medical
record, whether or not the individual has executed an advance
directive.
(d) Standard: Submission and investigation of grievances. The ASC
must establish a grievance procedure for documenting the existence,
submission, investigation, and disposition of a patient's written or
verbal grievance to the ASC. The following criteria must be met:
(1) All alleged violations/grievances relating, but not limited to,
mistreatment, neglect, verbal, mental, sexual, or physical abuse, must
be fully documented.
(2) Allegations of neglect, mistreatment, sexual or physical abuse
must be immediately reported to a person in authority in the ASC.
(3) Only substantiated allegations of neglect, mistreatment, sexual
or physical abuse must be reported to the applicable State authority or
the local authority, or both.
(4) The grievance process must specify timeframes for review of the
grievance and the provisions of a response.
(5) The ASC, in responding to the grievance, must investigate all
grievances made by a patient or the patient's representative or
surrogate regarding treatment or care that is (or fails to be)
furnished.
(6) The ASC must document how the grievance was addressed, as well
as provide the patient with written notice of its decision. The
decision must contain the name of an ASC contact person, the steps
taken to investigate the grievance, the result of the grievance
process, and the date the grievance process was completed.
(e) Standard: Exercise of rights and respect for property and
person.
(1) The patient has the right to
(i) Be free from any act of discrimination or reprisal.
(ii) Voice grievances regarding treatment or care that is (or fails
to be) provided.
(iii) Be fully informed about a treatment or procedure and the
expected outcome before it is performed.
(2) If a patient is adjudged incompetent under applicable State
health and safety laws by a court of proper jurisdiction, the rights of
the patient are exercised by the person appointed under State law to
act on the patient's behalf.
(3) If a State court has not adjudged a patient incompetent, any
legal representative or surrogate designated by the patient in
accordance with State law may exercise the patient's rights to the
extent allowed by State law.
(f) Standard: Privacy and safety. The patient has the right to the
following:
(1) Personal privacy.
(2) Receive care in a safe setting.
(3) Be free from all forms of abuse or harassment.
(g) Standard: Confidentiality of medical records. The ASC must
comply with the Department's rules for the privacy and security of
individually identifiable health information, as specified at 45 CFR
parts 160 and 164.
(h) Standard: Exception to the timing of the notice of patient
rights. In the case of an emergency procedure, when it is not feasible
to inform the patient or the patient's representative or surrogate of
the patient's rights in advance of the date of the procedure, the ASC
may provide the required notice and disclosures to the patient or the
patient's representative or surrogate immediately before the procedure
only if the following conditions are met:
(1) The signed physician referral is in writing, is dated the day
the patient presents at the ASC, and is placed in the patient's medical
record prior to the procedure.
(2) A physician in the ASC or the referring physician communicates
in writing and the ASC documents in the medical record that the
procedure must be performed as soon as possible to safeguard the health
of the patient.
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: January 21, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare & Medicaid Services.
Approved: April 5, 2010.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010-8903 Filed 4-22-10; 8:45 am]
BILLING CODE 4120-01-P